• Busca personas
• Intranet

Carcinogénesis gástroesofágica Manuel Pera

Publicaciones 2026 (21)

• Visa L, Badia J, Fernández MC, Saurí T, Macias I, Zhang N, Adeva J, Zumstein L, Peinado P, Ponz-Sarvisé M, Ceniceros L, Fabregat-Franco C, Caramés C, López AM, Salinas P, Monzonis X, Masfarre-Pinto L, Sibilio A, Riva F, Cubillo A, Faull I, Macarulla T, Iglesias M, Bellosillo B, Montagut C^*. Next generation sequencing of circulating tumor DNA for precision medicine in patients with advanced biliary tract cancers. Clin Cancer Res 2026: (en Premsa).
• Barman S, Chevallay M, Gisbertz SS, Van hemelrijck M, Byrne BE, Wijnhoven B, Markar S, Elliott JA, Bornschein J, Pritchard M, Nilsson M, Low D, Gutschow CA, Dunn JM, Zeki S, Ahmedzai SH, Laird B, Jafari J, Evans O, Peters CJ, Lagergren P, Lagergren J, Pera MR, Cornellas MD, Huddy F, Hobson A, Noor Z, Cockbain AJ, Klevebro F, Fox L, Moss C, Owen K, Phillips AM, Hoen CT, Ward E, White C, van Berge-Henegouwen MI, Mönig S, Noteboom L, Purushothaman K, Koessler T, Schneider MA, Masclee G, Geroin C, Weindelmayer J, Lazzaris S, Luyer M, Hedberg J, Sivanathan V, Reynolds J, Hölscher AH, Piessen G, Miller TE, Grocott M, Andreyev J, Davies A^*, EUROSTAR Study Faculty Members. EUropean consensus on the Resolution Of SympToms After oesophago-gastric Resection (EUROSTAR): Peri-Operative Quality Initiative (POQI) consensus statement. Gut 2026: (en Premsa).
  Cites:0
  Cites:0
• Dal Cero M, Martí Gelonch L, Eizaguirre E, Salvador H, Yarnoz C, Miranda C, Estremiana F, Miró M, Castro S, Gantxegi A, Gil-albarellos R, García-Tejero A, Olona C, Sarriugarte A, Codony C, Viciano M, Garsot E, Aldeano A, Montmany S, Luna A, Pulido L, PUÉRTOLAS N, Sánchez-Cano JJ, Gobbini Y, Hermoso J, Pi-Figueras M, Gimeno M, Gibert J, Manterola C, Grande L, Pera M, Spanish EURECCA Esophagogastric Cancer Group. Impact of frailty on outcomes in older patients after curative gastrectomy for cancer: a matched-pair analysis. Eur J Surg Oncol 2026; 52(12): 112172 (en Premsa).
  Cites:0
  Cites:0
• Vázquez-Bellón N, Rodríguez-Núñez M, Martínez-Bosch N, Barranco L, Visa L, García de Frutos P, Marco MP, Navarro P^*, Salvador JP^*. Lateral flow immunoassay detection of soluble AXL for pancreatic ductal adenocarcinoma diagnosis. Talanta 2026; 309: 129973.
  Cites:0
  Cites:0
• Rodó A, Martín-Ontiyuelo C, Rodríguez-Fuster A, Sánchez Font A, Chalela Rengifo R, Curull V, Belda J, Trujillo JC, Pera MR, Rodríguez-Chiaradía DA. Peak Workload as Predictor of Respiratory Complications in Patients Undergoing Resection for Lung Cancer. Respiration 2026; 105(8): 864-872.
  Cites:0
  Cites:0
• Schneider MA, Davies A, O'brien C, Baker C, Gossage J, Elliott J, Raftery N, Ahmed R, Klevebro F, Nilsson M, Norén N, Meier Adamenko O, Griffiths E, Butterworth W, Schlößer H, Bruns C, Tzitzili E, Nickel F, Kemper M, Zgurskyi P, Luyer M, Geraedts T, Bonavina L, Aiolfi A, Gockel I, Thieme R, Niebisch S, Kraljevic M, Müller B, Cron L, Berlth F, Milazzo A, Sgromo B, Harris H, Moletta L, Valmasoni M, Hubka M, Giacopuzzi S, Collizzolli A, Rosati R, Carresi A, Battaglia S, Santi S, Gualtierotti M, Rebecchi F, D'avalos LV, Pera MR, Biel E, Hölscher A, Hemmerich M, Cheong E, Van Daele E, Vanommeslaeghe H, Nezi G, Klarenbeek B, Grimminger P, Gutschow CA^*. Revisional surgery for delayed gastric conduit emptying after esophagectomy: the RESTORANT project. Dis Esophagus 2026; 39(5): doag107.
  Cites:0
  Cites:0
• Lara Santos L, Finamore AC, Gisbertz S, Fumagalli Romario U, Kielan W, Rosati R, Kolodziejczyk P, Wijnhoven B, Gockel I, Giacopuzzi S, Polkowski WP, Davies A, Morgagni P, Hoelscher A, Allum W, D'ugo D, Hartgrink H, Bencivenga M, Viganò J, Pera MR, Reim D, Schneider P, Mönig S, De Manzoni G, Baiocchi GL, Antunes C, Matos da Costa P^*, GASTRODATA Consortium (European Chapter of International Gastric Cancer Association). Bridging prediction and reality: AI-based external validation of predictive models for lymph node metastasis in gastric cancer. Eur J Surg Oncol 2026; 52(9): 111928.
  Cites:0
  Cites:0
• Molteni M, Puccetti F^*, Baiocchi GL, Piessen G, Allum W, Davies A, Hoelscher A, Gockel I, Reim D, Morgagni P, Fumagalli Romario U, D'ugo D, Reddavid R, De Manzoni G, Van Sandick J, Gisbertz S, Wijnhoven B, Polkowski W, Kolodziejczyk P, Kielan W, Matos da Costa P, Lara Santos L, Pera MR, Moenig S, Schneider PM, Gutschow CA, Elmore U, Rosati R, Other Members of the GASTRODATA Study Group. Standard reporting on duodenal stump leakage after gastric cancer resections: multicentre analysis from the GASTRODATA Study Group (the STARDUST study). Br J Surg 2026; 113(9): znag105.
  Cites:0
  Cites:0
• Martínez-Bosch N, Manero-Rupérez N, Vázquez-Bellón N, Nickell B, Ventura C, Lutfi N, Lechuga CG, Martínez C, Moreno M, Ampurdanés C, Abad E, Iglesias Coma M, Muñoz M, Janic A, Rovira M, Guerra C, Rabinovich GA, Yélamos J^*, Navarro P^*. PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity. Sci Adv 2026; 12(19): eadu8849.
  Cites:0
  Cites:0
• Salcedo Allende MT, Fuste Chimisana V, Zucchiatti Llanos AC, Serrano Piñol T, Cuatrecasas Freixas M, Archilla Sanz I, Ortiz MR, Melendez Muñoz C, Aula Olivar A, López Martos R, Hernandez Gallego A, Gené Hijos M, Diaz Fernández ML, Iglesias Coma M, González Muñoz C, Baez Leal CJ, Fumagalli C, Szafranska J, Vidal Borrego M, Sánchez Cabús S, Ferreres Piñas JC, Vaquero Raya EC. Position statement on the pathological assessment of pancreatic resection specimens in pancreatic ductal adenocarcinoma by the Societat Catalana de Pàncrees and the Societat Catalana d'Anatomia Patològica. Gastroenterol Hepatol 2026; 49(6): 502700.
  Cites:0
  Cites:0
• Biel E, Sánchez J, Pera MR^*. Dysphagia megalatriensis as differential diagnosis of recurrence in a long-term survivor of gastric cancer: an uncommon cause of dysphagia beyond the alimentary tract. J Gastrointest Surg 2026; 30(2): 102305.
  Cites:0
  Cites:0
• Martínez Ciarpaglini C, Ortega M, Pérez Buira S, Bolea A, Casado B, Herencia Bellido C, Tornero Piñero P, Naranjo Hans D, Palomar B, Quiceno H, Sardón Fernández A, Torner Calvo A, Rojo F^*, Iglesias Coma M. CLDN18.2 expression in gastroesophageal adenocarcinoma: prevalence, heterogeneity, and prognostic implications in Spanish patients. Virchows Arch 2026; 487(6): 1337-1346.
  Cites:1
  Cites:1
• Jiménez Fonseca P^*, Diez Garcia M, Catoya Villa JL, Pérez-Wert P, Visa L, Carmona Bayonas A, Limón ML, Fernández-Montes A, Reboredo M, Vidal R, Gallego Plazas J, Mendoza GE, Landolfi S, Teijo A, Guerra Pastrian L, Nieto A, Domínguez Miranda JL, López Vega ML, Rodríguez Gonzalez M, Illán Gambín FJ, Martinez de Castro E, Hierro C, Gil-Raga M, Robles González M, Moreno Gutiérrez ME, Vilanova D, Iglesias Coma M. Real-world characterization of PD-L1 expression in patients with advanced esophagogastric adenocarcinoma in Spain. 2026: (en Premsa).
  Cites:0
  Cites:0
• Carbonell Morote S, Daiko H, De Manzoni G, Gisbertz S, Yang HK, Polkowski W, Ramia JM^*, Pera MR^*, Collaborators. International Delphi consensus to define textbook outcome parameters for oncological gastrectomy (togs project). World J Surg Oncol . 2026; 24(1): 251.
  Cites:0
  Cites:0
• Iglesias Coma M^*, Badia J, Martínez Ciarpaglini C, Linares J, Tarazona N, Mulet-Margalef N, Tornero Piñero P, Sallent A, Recort-Bascuas A, Gibert J, Sant-Albors M, Tauriello DVF, Cruz M, Carreras M, Sancho E, Morral Martinez C, Garrido M, Manzano-Mozo JL, Cervantes A, Montagut C, Batlle E^*, Calon A^*. Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy. Gut 2026: (en Premsa).
  Cites:0
  Cites:0
• Mannucci A, Balaguer F, Yamada Y, Nagasaka T, Toiyama Y, Okugawa Y, Martí Gallostra M, JIimenez M, Vidal R, Jiménez F, Perea J, Quintero E, Boland CR, Cavestro GM, Goel A^*, SECOC-ENCODER Collaborators (...,Iglesias Coma M,...). An Exosome-Based Liquid Biopsy for the Detection of Early-Onset Colorectal Cancer: The ENCODER Multicenter Study. Gastroenterology 2026; 170(2): 330-343.
  Cites:3
  Cites:3
• Mateos L, Jiménez Fonseca P, Gallego J, Lecumberri A, Custodio A, Martinez de Castro E, Hernández San Gil R, Fernández Montes A, Limón ML, Vidal R, Cano JM, López Robles J, Gil M, Acosta Eyzaguirre D, Marín Zafra G, Mérida García AJ, Francisco Fernández A, Ribera Fernández P, Hierro C, Riesco MC, García Araque M, Ruiz Martín M, Pimentel P, Visa L, Cerdá P, Granja M, Rupérez Blanco AB, Gutierrez L, Carmona Bayonas A^*. Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis. Br J Cancer 2026; 134(3): 414-427.
  Cites:0
  Cites:0
• Solé L, Canton E, Maqueda M, Lobo T, Barbachano A, Torres F, Cabré Romans JJ, Montoto Á, Fernández-Ibarrondo L, Martínez-García D, Guix M, Larrubia-Loring M, Montagut C, Muñoz A, Bigas A, Iglesias Coma M, Bellosillo B, Espinosa L^*. ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumors. Br J Cancer 2026; 134(4): 638-649.
  Cites:0
  Cites:0
• Terán E^*, Pazo R, Caritá L, Alsina M, Hierro C, Blanco C, Reboredo M, Landolfi S, Zucchiatti A, Visa L, Calvo A, Lopez A, Vidal Tocino R, Agra C, Alés I, Foti S, Garcia Paredes B, Genovesi V, Fornaro L, Saurí T, Macias I, Martinez E, Martinez J, Bugés C, Ribera P, Herranz JM, Acosta D, Vivancos A, Tabernero J, Élez E, Tian T V, Macarulla T. Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohort. ESMO Open 2026; 11(2): 106053.
  Cites:1
  Cites:1
• Alvarez D, Maqueda M, Harti D, Canton E, Andrades E, Bertran J, Martínez-Iniesta M, Solé L, Garcia V, Montoto Á, Lobo T, Alonso Marañón J, Herrero P, Larrubia-Loring M, Tramuns A, Wynne K, Bera I, Matallanas D, Villanueva A, Bigas A, Iglesias Coma M, Espinosa L^*. Tight junction-high and CDH17-positive cell population is the source of colorectal cancer liver metastases. Nat Commun 2026; 17(1): 1425.
  Cites:1
  Cites:1
• Sen P^*, Broquetas M, Pera MR. Giant Brunner's gland hamartoma: the surgical management of complex cases. Ann Roy Coll Surg 2026: (en Premsa).